Research Feeds

View All
1H NMR- based metabolomics approaches as non-invasive tools for diagnosis of endometriosis A Comparative Study of Blood Levels of Manganese, Some Macroelements and Heavy Metals in Obese and Non-Obese Polycystic Ovary Syndrome Patients A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? A comprehensive analysis of breast cancer microbiota and host gene expression A comprehensive analysis of breast cancer microbiota and host gene expression A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women A metabonomics approach as a means for identification of potentialbiomarkers for early diagnosis of endometriosis A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis: A Pilot Study A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota A Review of the Anti-inflammatory Properties of Clindamycin in the Treatment of Acne Vulgaris A Systematic Review and Meta-Analysis of Premenstrual Syndrome with Special Emphasis on Herbal Medicine and Nutritional Supplements. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)

Did you know?
Mutations in the ESR1 gene can make estrogen receptors active without estrogen, driving cancer growth even during hormone therapy!

Estrogen Receptors (ER)

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

November 10, 2024

Estrogen receptors (Rs) are specialized proteins that respond to the hormone estrogen, playing a critical role in regulating biological processes such as reproduction, cellular growth, and differentiation.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Last Updated: November 9, 2024

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Overview

Estrogen receptors (ERs) are specialized proteins that respond to the hormone estrogen (17β-estradiol), playing a critical role in regulating biological processes such as reproduction, cellular growth, and differentiation. These receptors are categorized into two main classes: nuclear estrogen receptors (ERα and ERβ) and membrane estrogen receptors (mERs). Nuclear ERs function as transcription factors, translocating to the nucleus upon activation to bind specific DNA sequences and regulate gene expression, while also mediating non-genomic actions. In contrast, mERs, including GPER and ER-X, are G protein-coupled receptors that facilitate rapid estrogen signaling.

Clinical Significance of Estrogen Receptors (ERs)

Estrogen receptors (ERs) play a vital role in several physiological and pathological conditions. Their dysregulation is linked to various diseases, with the most notable being breast cancer, where ERs are overexpressed in approximately 70% of cases. These receptors also have implications in menopause, aging, obesity, and other conditions such as endometriosis and uterine fibroids. Understanding ER subtypes and their specific roles is crucial for developing targeted therapies, addressing resistance to treatment, and exploring new therapeutic options.

What conditions are associated with estrogen receptors (ERs)?

ConditionDetails
CancerER-positive breast cancer is driven by estrogen-ER binding, leading to increased cell division (raising mutation risks) and the production of genotoxic metabolites. Therapies include SERMs (e.g., tamoxifen), aromatase inhibitors (e.g., anastrozole), and ERβ-specific agonists (for colon cancer). Resistance challenges, such as ESR1 mutations, complicate treatment.
Menopause and AgingChanges in estrogen signaling during menopause, influenced by ER polymorphisms, impact metabolic health. Declining ERα expression in the hypothalamus with aging may be mitigated by caloric restriction, as demonstrated in animal studies.
Obesity and MetabolismEstrogen deficiency, particularly through dysfunctional ERα, is linked to increased fat deposition and obesity. Animal models confirm significant weight gain when estrogen pathways are disrupted.
Other ConditionsEndometriosis and Uterine Fibroids: SERMs are under investigation but lack conclusive evidence for efficacy.

– Estrogen Insensitivity Syndrome (EIS): A rare condition where nonfunctional ERs result in high estrogen levels without feminizing effects, leading to masculinization and infertility.

FAQs

What are the main types of estrogen receptors, and how do they differ?

The two main types of estrogen receptors are ERα and ERβ. ERα is primarily associated with promoting cell proliferation and tumorigenesis, while ERβ often exhibits protective effects in specific tissues. Understanding these differences is crucial for tailoring hormone therapies.

How do estrogen receptors contribute to cancer development?

In ER-positive breast cancer, estrogen-ER binding drives cell proliferation, increasing the risk of mutations. Additionally, estrogen metabolism produces genotoxic byproducts that disrupt normal cell function, contributing to tumor growth.

What therapies target estrogen receptors in cancer treatment?

Therapies include selective estrogen receptor modulators (SERMs), such as tamoxifen, which block estrogen’s effects in breast tissue, and aromatase inhibitors, like anastrozole, which reduce estrogen production. Emerging treatments also focus on ERβ-specific agonists, particularly for colon cancer.

What is the significance of ERβ in colon cancer?

ERβ is the predominant estrogen receptor in colon tissue and is believed to have protective effects. Loss of ERβ is associated with advanced colon cancer, and ERβ-specific agonists are being explored as potential therapies.

Can estrogen receptors contribute to resistance in cancer treatment?

Yes, mutations in the ESR1 gene can make tumors resistant to endocrine therapies. These mutations allow ERα to remain active even without estrogen, promoting cancer progression despite treatment.

Are there conditions beyond cancer that involve estrogen receptors?

Yes, estrogen receptors are implicated in conditions such as endometriosis, uterine fibroids, and obesity. Rare conditions like estrogen insensitivity syndrome also highlight the critical roles of these receptors in human health.

What role do estrogen receptors play in obesity?

Dysfunction or deficiency in ERα has been linked to increased fat deposition and obesity. Studies in animal models have shown significant weight gain when estrogen pathways are disrupted.

Estrogen

Estrogen is a steroid hormone primarily found in women, crucial for reproductive health, secondary sexual characteristics, and various physiological processes. It regulates menstrual cycles, supports pregnancy, and influences bone density and cardiovascular health. Dysregulation of estrogen levels can lead to various disorders and health complications.

Endometriosis

Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.

Endometriosis

Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.